United Therapeutics (UTHR) Tops Q3 EPS by 194c
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $512.42 -0.14%
Financial Fact:
Net product sales: 408.2M
Today's EPS Names:
XYF, SQZB, RENO, More
Financial Fact:
Net product sales: 408.2M
Today's EPS Names:
XYF, SQZB, RENO, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $3.91, $1.94 better than the analyst estimate of $1.97. Revenue for the quarter came in at $330 million versus the consensus estimate of $335.1 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gogoro Inc (GGR) Reports Q2 Loss of $0.24, Offers FY26 Revenue Guidance
- H.B. Fuller board rejects Ancora's $1.1B-$1.2B BAS unit bid
- Morgan Stanley sees quality stocks and AI adopters leading market
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
